elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28543732-810C6321-A572-4486-91C0-F55E9995011D
Q28543732-810C6321-A572-4486-91C0-F55E9995011D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28543732-810C6321-A572-4486-91C0-F55E9995011D
Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infection
P356
Q28543732-810C6321-A572-4486-91C0-F55E9995011D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28543732-810C6321-A572-4486-91C0-F55E9995011D
rank
NormalRank
type
BestRank
Statement
P356
10.1371/JOURNAL.PONE.0118228
http://www.w3.org/2001/XMLSchema#string
P356
JOURNAL.PONE.0118228